Risk of pneumonia in patients taking statins: population-based nested case-control study

Vinogradova, Yana; Coupland, Carol; Hippisley-Cox, Julia
November 2011
British Journal of General Practice;Nov2011, Vol. 61 Issue 592, p678
Academic Journal
The article discusses a study on the association of current exposure to statins with risk of community-acquired pneumonia. The study chose patients aged 45 years and older and identified newly recorded cases of pneumonia during a 10 year study period. It concludes a significant association between statin use and decreased pneumonia risk for the two common statins, simvastatin and atorvastatin although randomised controlled trials are needed before any changes are made in clinical practice.


Related Articles

  • Review of cardiovascular literature. Hage, Fadi; AlJaroudi, Wael // Journal of Nuclear Cardiology;Apr2015, Vol. 22 Issue 2, p246 

    No abstract available.

  • Atorvastatin added to interferon beta for relapsing multiple sclerosis: a randomized controlled trial. Kamm, Christian; El-Koussy, Marwan; Humpert, Sebastian; Findling, Oliver; Bredow, Ferdinand; Burren, Yuliya; Schwegler, Guido; Schött, Dagmar; Donati, Filippo; Müller, Martin; Goebels, Norbert; Müller, Felix; Slotboom, Johannes; Tettenborn, Barbara; Kappos, Ludwig; Naegelin, Yvonne; Mattle, Heinrich // Journal of Neurology;Nov2012, Vol. 259 Issue 11, p2401 

    Statins have anti-inflammatory and immunomodulatory properties in addition to lipid-lowering effects. The present study evaluated the effect of atorvastatin added to interferon beta-1b in multiple sclerosis (MS) in a multicenter, randomized, parallel-group, rater-blinded study performed in eight...

  • Effects of Preoperative Short Term Use of Atorvastatin on Endothelial Progenitor Cells after Coronary Surgery: A Randomized, Controlled Trial. Baran, Çağdaş; Durdu, Serkan; Dalva, Klara; Zaim, Çagın; Dogan, Arın; Ocakoglu, Gokhan; Gürman, Günhan; Arslan, Önder; Akar, Ahmet // Stem Cell Reviews & Reports;Sep2012, Vol. 8 Issue 3, p963 

    Objectives: We investigated the effects of short-term use of atorvastatin on CD34+/VEGF-R2+/CD133+/CD45- endothelial progenitor cell (EPC) count after on-pump coronary artery bypass surgery (CABG). Methods: Between Feb-2010 and May-2010, we randomly assigned, in a placebo-controlled,...

  • Antibiotic coprescription and statins.  // Neurology Alert;Aug2013 Pharmacology Watch, p2 

    The article discusses a study published in a 2013 issue of "Annals of Internal Medicine" which cautioned the use of the antibiotic clarithromycin or erythromycin on patients using statins as this can lead to hospitalization for rhabdomyolysis particularly among patients with acute kidney injury.

  • 2014 - Pooled RCTs: Atorvastatin did not increase renal-related serious adverse events. Herrington, William; Haynes, Richard; Waters, D.D. // ACP Journal Club;10/1/2014, Vol. 161 Issue 8, p7 

    The article presents a study which is focused on analyzing the effect of statin atorvastatin and placebo on the serious adverse events (SAEs) related to renal diseases. The study was conducted on 290 patients by using the more or less intensive statin therapy. According to the results, the...

  • Preface. Johnson, Alan P.; Leibovici, Leonard // Journal of Antimicrobial Chemotherapy (JAC);Apr2011 Supplement 3, Vol. 66 Issue suppl_3, piii1 

    The article introduces a series of reports on the efficacy and safety of ceftaroline fosamil based on two randomized controlled trials of community-associated pneumonia (CAP), published within the issue.

  • Atorvastatin is as potent as amlodipine.  // Australian Journal of Pharmacy;Mar2011, Vol. 92 Issue 1090, p75 

    The article offers information on a randomised, double-blind, parallel group, multi-country trial that investigates whether atorvastatin decreases ischaemia by a vascular benefit, independent of low density lipoprotein cholesterol lowering, in patients with coronary artery disease (CAD).

  • Paper of the month.  // Pulse;May2013, p19 

    The article reports on the findings of a research which aims to track patients who stopped statin treatment because of a presumed statin-related side-effect and to know how many tried to take a statin again and what percentage of that group went on to achieve long-term use.

  • Hyperlipidaemia. Ahmad, Rajai; Russell, David // Pulse;Sep2014, p90 

    The article presents questions and answers related to general practitioners (GP) which include why GP does not consider statin for patients with cardiovascular disease risk, the benefits of statin on patients with diabetes, and the efficacy of atorvastatin for 85 years old patients.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics